MY170840A - Aqueous composition containing 2-amino-3-(4-bromobenzoyl) phenylacetic acid - Google Patents

Aqueous composition containing 2-amino-3-(4-bromobenzoyl) phenylacetic acid

Info

Publication number
MY170840A
MY170840A MYPI2014702590A MYPI2014702590A MY170840A MY 170840 A MY170840 A MY 170840A MY PI2014702590 A MYPI2014702590 A MY PI2014702590A MY PI2014702590 A MYPI2014702590 A MY PI2014702590A MY 170840 A MY170840 A MY 170840A
Authority
MY
Malaysia
Prior art keywords
bromobenzoyl
amino
phenylacetic acid
aqueous composition
composition containing
Prior art date
Application number
MYPI2014702590A
Other languages
English (en)
Inventor
Takashi Morimoto
Hiroyuki Asada
Kyohei Takahashi
Tomoyuki Okamoto
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Publication of MY170840A publication Critical patent/MY170840A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
MYPI2014702590A 2012-03-28 2013-03-28 Aqueous composition containing 2-amino-3-(4-bromobenzoyl) phenylacetic acid MY170840A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2012073181 2012-03-28

Publications (1)

Publication Number Publication Date
MY170840A true MY170840A (en) 2019-09-10

Family

ID=49260248

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2014702590A MY170840A (en) 2012-03-28 2013-03-28 Aqueous composition containing 2-amino-3-(4-bromobenzoyl) phenylacetic acid

Country Status (9)

Country Link
JP (1) JP5922609B2 (ja)
KR (1) KR20140139501A (ja)
CN (1) CN104203224A (ja)
IN (1) IN2014DN07767A (ja)
MY (1) MY170840A (ja)
PH (1) PH12014502171A1 (ja)
SG (1) SG11201405837YA (ja)
TW (1) TWI604858B (ja)
WO (1) WO2013147000A1 (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017002042A (ja) * 2015-06-10 2017-01-05 参天製薬株式会社 点眼剤、及び点眼剤防腐効力維持方法
CN111712238A (zh) * 2017-12-14 2020-09-25 参天制药株式会社 含有2-氨基-3-（4-溴苯甲酰基）苯乙酸或其盐的滴眼剂
CN114224830A (zh) * 2021-12-24 2022-03-25 辰欣药业股份有限公司 一种单剂量无抑菌剂的眼用制剂及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002308764A (ja) * 2001-02-09 2002-10-23 Taisho Pharmaceut Co Ltd 眼科用医薬組成物
JP4674162B2 (ja) * 2003-11-14 2011-04-20 千寿製薬株式会社 アミノグリコシド系抗生物質およびブロムフェナクを含有する水溶液製剤
CN1823754A (zh) * 2006-03-28 2006-08-30 卢秀莲 溴芬酸钠滴眼液及其制备方法
CN101313899B (zh) * 2007-06-01 2012-02-29 北京德众万全药物技术开发有限公司 一种含有溴芬酸钠的眼用药物组合物
JP2011513229A (ja) * 2008-02-21 2011-04-28 イスタ・ファーマスーティカルズ・インコーポレイテッド 補助剤としての眼科用ｎｓａｉｄ
CN101322683B (zh) * 2008-07-30 2013-01-16 浙江三叶药业有限公司 一种含有溴芬酸钠水合物的眼用凝胶剂及其制备方法
BR112013018025A2 (pt) * 2011-01-18 2020-10-27 Senju Pharmaceutical Co., Ltd composição de bromfenac líquida aquosa método para reforçar a eficácia conservante de uma solução aquosa
JP6012231B2 (ja) * 2011-04-08 2016-10-25 ロート製薬株式会社 ブロムフェナク含有組成物

Also Published As

Publication number Publication date
PH12014502171A1 (en) 2014-12-10
KR20140139501A (ko) 2014-12-05
TWI604858B (zh) 2017-11-11
TW201343197A (zh) 2013-11-01
WO2013147000A1 (ja) 2013-10-03
CN104203224A (zh) 2014-12-10
JP5922609B2 (ja) 2016-05-24
SG11201405837YA (en) 2014-11-27
JP2013227300A (ja) 2013-11-07
IN2014DN07767A (ja) 2015-05-15

Similar Documents

Publication Publication Date Title
MX2021009672A (es) Regulacion transcripcional guiada por acido ribonucleico.
BR112015000561A2 (pt) inibidores de irak e usos dos mesmos
EA201791717A1 (ru) Стабильные водные составы адалимумаба
PH12015501328A1 (en) Meglumine salt of 6-flouro-3-hydroxy-2-pyrazine carboxamide
UA111542C2 (uk) Похідне складного ефіру 2-амінонікотинової кислоти та бактерицид, що містить зазначене похідне як активний інгредієнт
MX2012012530A (es) Derivados de n1-sulfonil-5-fluorpirimidinona.
EA201390081A1 (ru) Дейтерированный n-этил-n-фенил-1,2-дигидро-4-гидрокси-5-хлор-1-метил-2-оксохинолин-3-карбоксамид, его соли и их применение
UA107865C2 (ru) Гетероциклические карбоксамиды
BR112014028334A2 (pt) derivados dipeptídicos de lisina ácido glutâmico.
IN2015DN00402A (ja)
EA201590617A1 (ru) Композиции алкилированного циклодекстрина и способы их получения и применения
CA2905610C (en) Hyaluronic acid derivatives
MX2014014464A (es) Peptidos penetrantes de celulas y metodos para identificar peptidos penetrantes de celulas.
MX346678B (es) Sales de arginina utiles inmunologicamente.
MX2013007436A (es) Uso de estabilizadores de glutamina.
UA111333C2 (uk) Спосіб одержання l-аргінінової солі периндроприлу
PH12016501005A1 (en) Anti-malodor oral care composition
IN2015DN03975A (ja)
EA201590708A1 (ru) Модифицированные производные гиалуроновой кислоты и их применение
IN2015DN02668A (ja)
MY170840A (en) Aqueous composition containing 2-amino-3-(4-bromobenzoyl) phenylacetic acid
UA115072C2 (uk) Похідні гідантоїну
MX2013008277A (es) Composicion liquida y acousa de bromfenaco, que tiene efectividad conservadora.
GT201300003A (es) Forma cristalina delta de la sal de arginina de perindoprilo, su procedimiento de preparacion , y las composiciones farmacèuticas que la contienen
PL2919755T3 (pl) Wodna ciekła kompozycja zawierająca kwas 2-amino-3-(4-bromobenzoilo)fenylooctowy